American Society of Hematology, Blood Advances, 15(3), p. 2312-2316, 2019
DOI: 10.1182/bloodadvances.2019000034
Full text: Download
Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.